PMV Pharmaceuticals, Inc. (PMVP) News
Follow PMV Pharmaceuticals, Inc. (PMVP) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 16 public stories across 6 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
L
PMV Pharmaceuticals appoints Philip Herman as Chief Commercial Officer
PMV Pharmaceuticals appointed Philip Herman as Chief Commercial Officer.
EQUITY | Sep 08, 2026, 12:01 PM UTC
L
HC Wainwright maintains PMV Pharmaceuticals $5.00 price target
HC Wainwright & Co. maintained its price target for PMV Pharmaceuticals at $5.00 per share, according to Benzinga ratings actions.
EQUITY | Sep 04, 2026, 11:52 AM UTC
M
PMV Pharmaceuticals sets underwritten equity offering with TD Securities
PMV Pharmaceuticals entered an underwriting agreement with TD Securities for an underwritten offering of common stock, pre-funded warrants, and accompanying common stock warrants, expected to close Sep 02, 2026.
EQUITY | Sep 02, 2026, 10:04 AM UTC
L
PMV Pharma: TD Cowen Is Sole Bookrunning Manager >PMVP
PMV Pharma: TD Cowen Is Sole Bookrunning Manager >PMVP
EQUITY | Sep 01, 2026, 03:39 AM UTC
L
PMV Pharma expects offering to close on or about Sept. 2
PMV Pharma expects its offering to close on or about Sept. 2.
EQUITY | Sep 01, 2026, 03:38 AM UTC
L
PMV Pharma expects $50.8M gross proceeds from offering
PMV Pharma expects gross proceeds of $50.8M from its offering.
EQUITY | Sep 01, 2026, 03:38 AM UTC
L
PMV Pharma Selling All Securities Being Sold in Offering >PMVP
PMV Pharma Selling All Securities Being Sold in Offering >PMVP
EQUITY | Sep 01, 2026, 03:38 AM UTC
L
PMV Pharma sets combined offering price for prefunded warrants
PMV Pharma set the combined offering price of each prefunded warrant and accompanying warrant at $1.20999 for PMVP.
EQUITY | Sep 01, 2026, 03:37 AM UTC
L
PMV Pharma sets $1.21 combined offering price per share+warrant
PMV Pharma said the combined offering price of each share and accompanying warrant is $1.21 for PMVP.
EQUITY | Sep 01, 2026, 03:37 AM UTC
M
PMV Pharma offering: 22.1M shares, prefunded warrants for 19.9M shares
PMV Pharma’s offering includes 22.1M shares and prefunded warrants allowing some investors to buy 19.9M shares in lieu of common stock.
EQUITY | Sep 01, 2026, 03:29 AM UTC
L
PMV Pharmaceuticals Offering Also Comprises Accompanying Warrants to Purchase 42M Shrs >PMVP
PMV Pharmaceuticals Offering Also Comprises Accompanying Warrants to Purchase 42M Shrs >PMVP
EQUITY | Sep 01, 2026, 03:20 AM UTC
L
PMV Pharma prices oversubscribed $50 million public offering
PMV Pharma announced pricing of an oversubscribed $50 million public offering of securities.
EQUITY | Sep 01, 2026, 03:07 AM UTC
M
PMV Pharmaceuticals reports 46% ORR and plans Q1 2027 NDA filing
PMV Pharmaceuticals says its ovarian cohort generated a 46% ORR and it plans an NDA filing in Q1 2027.
EQUITY | Aug 31, 2026, 08:14 PM UTC
M
PMVP Pharmaceuticals updates interim ovarian cancer monotherapy data
PMV Pharmaceuticals announced updated interim ovarian cancer data from its PYNNACLE Phase 2 pivotal trial for rezatapopt monotherapy.
EQUITY | Aug 31, 2026, 08:07 PM UTC
L
PMV Pharma proposes public offering of securities
PMV Pharma (PMVP) announced a proposed public offering of securities.
EQUITY | Aug 31, 2026, 08:02 PM UTC
L
PMV Pharmaceuticals reports Q2 2026 financial results and highlights
PMV Pharmaceuticals (PMVP) reports second quarter 2026 financial results and corporate highlights.
EARNINGS | Aug 14, 2026, 12:00 PM UTC